We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

By MedImaging International staff writers
Posted on 22 Mar 2024

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without prompt treatment. Considering the importance of early detection, researchers have now developed an artificial intelligence (AI) system that automatically and reliably detects cardiac amyloidosis during scintigraphy imaging.

The new AI system was developed and validated by an international research team led by Medical University Vienna (Vienna, Austria), utilizing data sets from 16,000 patients who underwent a scintigraphy imaging examination across Europe and Asia between 2010 and 2020. Scintigraphy, a nuclear medicine procedure, is instrumental in identifying various diseases, such as cancer, thyroid, kidney, and heart disease. The AI tool significantly enhances the speed of diagnosing cardiac amyloidosis by automatically detecting the condition during the scintigraphy imaging process.


Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

The AI system’s accuracy was also rigorously tested by comparing it with the diagnostic capabilities of medical professionals. The results showed that the AI tool could identify cardiac amyloidosis with a reliability that matches or even surpasses that of medical experts. Further analysis by the research team delved into the relationship between AI-detected diagnoses of cardiac amyloidosis and subsequent health outcomes. The findings revealed that patients diagnosed with the condition by the AI tool faced double the risk of mortality and a more than seventeen-fold increase in the risk of developing heart failure compared to those not diagnosed with amyloidosis by the AI system.

"In the future, our findings and the technology we have developed could enable screening for cardiac amyloidosis among all scintigraphy patients, with the AI system evaluating the image data in parallel with doctors," said Clemens Spielvogel from MedUni Vienna's Department of Biomedical Imaging and Image-guided Therapy.

Related Links:
Medical University Vienna


New
Gold Member
X-Ray QA Meter
T3 AD Pro
New
Digital Radiographic System
OMNERA 300M
Wall Fixtures
MRI SERIES
New
Digital Radiography System
DigiEye 330

Latest Nuclear Medicine News

New Scans Light Up Aggressive Tumors for Better Treatment

AI Stroke Brain Scan Readings Twice as Accurate as Current Method

AI Analysis of PET/CT Images Predicts Side Effects of Immunotherapy in Lung Cancer